TAE Life Sciences
  • OUR COMPANY
    • ABOUT US
    • LEADERSHIP TEAM
    • BOARD OF DIRECTORS
    • ADVISORS
    • CAREERS
  • ABOUT BNCT
    • HISTORY
    • HOW IT WORKS
    • BENEFITS OF BNCT
  • OUR TECHNOLOGIES
    • ALPHABEAM NEUTRON SYSTEM
    • TARGETED BORON DRUGS
  • NEWS
    • NEWS
    • EVENTS
  • CONTACT US
  • NEW EBOOK
  • OUR COMPANY
    • ABOUT US
    • LEADERSHIP TEAM
    • BOARD OF DIRECTORS
    • ADVISORS
    • CAREERS
  • ABOUT BNCT
    • HISTORY
    • HOW IT WORKS
    • BENEFITS OF BNCT
  • OUR TECHNOLOGIES
    • ALPHABEAM NEUTRON SYSTEM
    • TARGETED BORON DRUGS
  • NEWS
    • NEWS
    • EVENTS
  • CONTACT US
  • NEW EBOOK

News

Chemical & Engineering News
March 13, 2018

$40 Million for Boron Neutron Capture Therapy

2018 | Chemical & Engineering News | Read Now

TAE Life Sciences aims to commercialize a cancer radiation treatment called Boron Neutron Capture Therapy. In BNCT, boron-10 is administered to tumors, irradiated with a beam of neutrons, and broken down into charged particles that kill cancer cells.

Miles-OBrien-Productions-e1521490687616-1179×1179
March 13, 2018

A Surprise Application To Cancer

2018 | Miles O’Brien| Read Now

There’s a radiological medical technique called Boron Neutron Capture Therapy (BNCT), which is like a very targeted chemotherapy.

GreenBiz
March 12, 2018

TAE Life Sciences Is Trying To Make Boron Neutron Capture Therapy More Accessible

2018 | GreenBiz | Read Now

The neutron beam is aimed at the cancer patient’s tumors for about 30 minutes, and is combined with a boron-based substance that is injected into the patient intravenously and accumulates in the cancer cells.

GeekWire
March 12, 2018

TAE Life Sciences Announces $40 Million In Venture Capital

2018 | Geekwire| Read Now

BNCT is a particularly promising technique for treating cancers of the head and neck region that are difficult or impossible to treat using other types of therapy. The procedure has already been tested in Japan, the United States and other locales.

TAE Life Sciences Press Release
March 12, 2018

TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

March 2018 | PR Newswire| Read Now

TAE Life Sciences is the first to license TAE Technologies’ accelerator-based neutron beam technology for clinical investigation of Boron Neutron Capture Therapy (BNCT).

Newer
12
Older

Sign up for our latest news and information

* indicates required




TAE Life Sciences, 19631 Pauling, Foothill Ranch, CA 92610

* The TAE Life Sciences device and drugs are in development and not available for sale or commercial use

Copyright ©2020 TAE Life Sciences. All Rights Reserved.